4-أمينوكينولين
| |
| |
| الأسماء | |
|---|---|
| اسم أيوپاك المفضل
Quinolin-4-amine | |
| Identifiers | |
| رقم CAS | |
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.167.771 
|
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| InChI | InChI={{{value}}} |
| SMILES | |
| الخصائص | |
| الصيغة الجزيئية | C9H8N2 |
| كتلة مولية | 144.17 g mol-1 |
| المظهر | Powder to crystalline, White/Yellow/Orange |
| نقطة الانصهار | |
| المخاطر | |
| خطر رئيسي | Causes skin and serious eye irritation |
ما لم يُذكر غير ذلك، البيانات المعطاة للمواد في حالاتهم العيارية (عند 25 °س [77 °ف]، 100 kPa). | |
 verify (what is  ?)
| |
| مراجع الجدول | |
4-Aminoquinoline is a form of aminoquinoline with the amino group at the 4-position of the quinoline. The compound has been used as a precursor for the synthesis of its derivatives.[1]
A variety of derivatives of 4-aminoquinoline are antimalarial agents useful in treating erythrocytic plasmodial infections.[2] Examples include amodiaquine, chloroquine, and hydroxychloroquine.[3] Other uses for the derivatives are: anti-asthmatic, antibacterial, anti-fungal, anti-malarial, antiviral and anti-inflammatory agents. [1]
A patent application for 4-aminoquinoline compounds was filed in 2002 and published in 2005.[4]
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See also
References
- ^ أ ب Al-Ahmary, Khairia M.; Alenezi, Maha S.; Habeeb, Moustafa M. (2016-08-01). "Synthesis, spectroscopic and DFT theoretical studies on the hydrogen bonded charge transfer complex of 4-aminoquinoline with chloranilic acid". Journal of Molecular Liquids (in الإنجليزية). 220: 166–182. doi:10.1016/j.molliq.2016.04.074. ISSN 0167-7322.
- ^ Bosak, Anita; Opsenica, Dejan M.; Šinko, Goran; Zlatar, Matija; Kovarik, Zrinka (2019-08-01). "Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase". Chemico-Biological Interactions (in الإنجليزية). 308: 101–109. doi:10.1016/j.cbi.2019.05.024. ISSN 0009-2797. PMID 31100281.
- ^ Bray PG, Hawley SR, Ward SA (1996). "4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake". Mol. Pharmacol. 50 (6): 1551–8. PMID 8967977.
- ^ DeVita, Robert; Chang, Lehua (13 January 2005). "4-Aminoquinoline Compounds" (PDF). United States Patent Application Publication.
External links
- Bourne SA, De Villiers K, Egan TJ (2006). "Three 4-aminoquinolines of antimalarial interest". Acta Crystallogr C. 62 (Pt 2): o53–7. doi:10.1107/S0108270105041235. PMID 16456284.
- "4-Aminoquinoline 578-68-7 | TCI America". www.tcichemicals.com. Retrieved 2020-03-06.